Pfizer Went From Covid Star to Activist Target as Stock Fell
Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its embattled chief executive face a long war against an activist that hates to lose.
Pfizer Is Clashing With Its New Activist Investor. Will It Harm The Stock?
Will this clash between a major shareholder and management, current and former, harm the stock? Or is the situation merely an awkward and public miscommunication between actors with aligned interests?
An Activist Investor Just Bought $1 Billion Worth of Pfizer. Here's What It Means for the Stock
On Oct. 6, The Wall Street Journal reported that activist investor group Starboard Value owns a stake in Pfizer (NYSE: PFE) that's worth approximately $1 billion. Now, Starboard will aim to work with the company's management as well as consult with former executives -- all with the aim of turning around Pfizer's sagging fortunes.
Activist investor Starboard cries foul play in exec U-turn at Pfizer
Starboard has accused Pfizer of “coercive conduct” after executives who initially backed the hedge fund retracted their support.
Activist Investor Starboard Value Presses Pfizer's Board Amid Corporate Tensions
The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard pushed Pfizers board to investigate alleged coercive actions. This follows the
The Motley Fool10h
Why I'm Considering Leaning Heavily Into Pfizer
Pfizer offers a generous 5.73% dividend yield. The stock is trading at an attractive forward P/E of 9.5x 2026 earnings.
What's Happening With Pfizer Stock?
Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...
Pfizer taps Vanguard veteran for board amid fight with Starboard
Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as ...
Which Pharma Stock Is the Better Bargain Buy: Pfizer or Eli Lilly?
With valuations growing across the stock market and the biopharma sector, it's only natural for value-sensitive investors to ...
Pfizer Inc. stock underperforms Tuesday when compared to competitors despite daily gains
The stock's rise snapped a three-day losing streak.
After Pfizer’s coronavirus vaccine success, CEO targeted for revenue slump
Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...
What Critics of Pfizer Are Getting Wrong
The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...
Pfizer’s stock dips after two former execs say they won’t support Starboard
Pfizer Inc.’s stock dipped 2.5% Thursday after two of its former executives said they would not support an effort by activist ...
Why Pfizer Stock Popped on Monday
Pfizer ( PFE 3.18%) stock jumped 3.1% through 11:20 a.m. ET Monday morning in response to a Wall Street Journal article over ...